EphA2 is a functional receptor for the growth factor progranulin

被引:102
|
作者
Neill, Thomas [1 ,2 ]
Buraschi, Simone [1 ,2 ]
Goyal, Atul [1 ,2 ]
Sharpe, Catherine [1 ,2 ]
Natkanski, Elizabeth [1 ,2 ]
Schaefer, Liliana [5 ]
Morrione, Andrea [3 ,4 ]
Iozzo, Renato V. [1 ,2 ]
机构
[1] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Pathol Anat & Cell Biol, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Canc Cell Biol & Signaling Program, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Urol, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[4] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Biol Prostate Canc Program, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[5] Goethe Univ, Inst Pharmacol & Toxicol, D-60323 Frankfurt, Germany
来源
JOURNAL OF CELL BIOLOGY | 2016年 / 215卷 / 05期
基金
美国国家卫生研究院;
关键词
FRONTOTEMPORAL LOBAR DEGENERATION; GRANULIN-EPITHELIN PRECURSOR; TYROSINE KINASE; CANCER-CELLS; BLADDER-CANCER; METASTATIC PROGRESSION; MONOMERIC EPHRINA1; TUMOR ANGIOGENESIS; ADIPOSE-TISSUE; TNF RECEPTORS;
D O I
10.1083/jcb.201603079
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Although the growth factor progranulin was discovered more than two decades ago, the functional receptor remains elusive. Here, we discovered that EphA2, a member of the large family of Ephrin receptor tyrosine kinases, is a functional signaling receptor for progranulin. Recombinant progranulin bound with high affinity to EphA2 in both solid phase and solution. Interaction of progranulin with EphA2 caused prolonged activation of the receptor, downstream stimulation of mitogen-activated protein kinase and Akt, and promotion of capillary morphogenesis. Furthermore, we found an autoregulatory mechanism of progranulin whereby a feed-forward loop occurred in an EphA2-dependent manner that was independent of the endocytic receptor sortilin. The discovery of a functional signaling receptor for progranulin offers a new avenue for understanding the underlying mode of action of progranulin in cancer progression, tumor angiogenesis, and perhaps neurodegenerative diseases.
引用
收藏
页码:687 / 703
页数:17
相关论文
共 50 条
  • [21] Silencing receptor EphA2 induces apoptosis and attenuates tumor growth in malignant mesothelioma
    Mohammed, Kamal A.
    Wang, Xiaohong
    Goldberg, Eugene P.
    Antony, Veena B.
    Nasreen, Najmunnisa
    AMERICAN JOURNAL OF CANCER RESEARCH, 2011, 1 (03): : 419 - 431
  • [22] EphA2 overexpression promotes ovarian cancer growth
    Lu, Chunhua
    Shahzad, Mian M. K.
    Wang, Hua
    Landen, Charles N.
    Kim, Seung W.
    Allen, Julie
    Nick, Alpa M.
    Jennings, Nicholas
    Kinch, Michael S.
    Bar-Eli, Menashe
    Sood, Anil K.
    CANCER BIOLOGY & THERAPY, 2008, 7 (07) : 1098 - 1103
  • [23] Structural and Functional Characterization of Monomeric EphrinA1 Binding Site to EphA2 Receptor
    Tome, Carla M. Lema
    Palma, Enzo
    Ferluga, Sara
    Lowther, W. Todd
    Hantgan, Roy
    Wykosky, Jill
    Debinski, Waldemar
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (17) : 14012 - 14022
  • [24] EPHA2 receptor is involved in in vivo acquired resistance to anti-epidermal growth factor receptor (EGFR) treatment in metastatic colorectal cancer
    Martini, G.
    Belli, V.
    Vitiello, P. P.
    Troiani, T.
    Cardone, C.
    Napolitano, S.
    Matrone, N.
    Sforza, V.
    Savastano, B.
    Renato, F.
    Morgillo, F.
    Della Corte, C. M.
    Ciardiello, D.
    Giunta, E. F.
    De Falco, V.
    Zanaletti, N.
    Vitale, P.
    Ciardiello, F.
    Martinelli, E.
    ANNALS OF ONCOLOGY, 2017, 28
  • [25] Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase
    Bin Fang, Wei
    Brantley-Sieders, Dana M.
    Hwang, Yoonha
    Ham, Amy-Joan L.
    Chen, Jin
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (23) : 16017 - 16026
  • [26] EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal Cancer
    Martini, Giulia
    Cardone, Claudia
    Vitiello, Pietro Paolo
    Belli, Valentina
    Napolitano, Stefania
    Troiani, Teresa
    Ciardiello, Davide
    Della Corte, Carminia Maria
    Morgillo, Floriana
    Matrone, Nunzia
    Sforza, Vincenzo
    Papaccio, Gianpaolo
    Desiderio, Vincenzo
    Paul, Mariel C.
    Moreno-Viedma, Veronica
    Normanno, Nicola
    Rachiglio, Anna Maria
    Tirino, Virginia
    Maiello, Evaristo
    Latiano, Tiziana Pia
    Rizzi, Daniele
    Signoriello, Giuseppe
    Sibilia, Maria
    Ciardiello, Fortunato
    Martinelli, Erika
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (04) : 845 - 855
  • [27] Conformational Clamping by a Membrane Ligand Activates the EphA2 Receptor
    Westerfield, Justin M.
    Sahoo, Amita R.
    Alves, Daiane S.
    Grau, Brayan
    Cameron, Alayna
    Maxwell, Mikayla
    Schuster, Jennifer A.
    Souza, Paulo C. T.
    Mingarro, Ismael
    Buck, Matthias
    Barrera, Francisco N.
    JOURNAL OF MOLECULAR BIOLOGY, 2021, 433 (18)
  • [28] Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer
    Michael S. Kinch
    Kelly Carles-Kinch
    Clinical & Experimental Metastasis, 2003, 20 : 59 - 68
  • [29] Cholesterol inhibits assembly and oncogenic activation of the EphA2 receptor
    Schuck, Ryan J.
    Ward, Alyssa E.
    Sahoo, Amita R.
    Rybak, Jennifer A.
    Pyron, Robert J.
    Trybala, Thomas N.
    Simmons, Timothy B.
    Baccile, Joshua A.
    Sgouralis, Ioannis
    Buck, Matthias
    Lamichhane, Rajan
    Barrera, Francisco N.
    COMMUNICATIONS BIOLOGY, 2025, 8 (01)
  • [30] EphA2 Is a Lung Epithelial Cell Receptor for Pneumocystis β-Glucans
    Kottom, Theodore J.
    Schaefbauer, Kyle
    Carmona, Eva M.
    Limper, Andrew H.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 225 (03): : 525 - 530